Polycystic ovary syndrome risk factors: Difference between revisions
Aditya Ganti (talk | contribs) |
Aditya Ganti (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Polycystic ovary syndrome}} | {{Polycystic ovary syndrome}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{ADG}} | ||
==Overview== | ==Overview== | ||
Revision as of 19:59, 24 July 2017
|
Polycystic ovary syndrome Microchapters |
|
Differentiating Polycystic ovary syndrome from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Polycystic ovary syndrome risk factors On the Web |
|
American Roentgen Ray Society Images of Polycystic ovary syndrome risk factors |
|
Risk calculators and risk factors for Polycystic ovary syndrome risk factors |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
Common risk factors in the development of Polycystic ovary syndrome are hyperinsulinemia secondary to insulin resistance, obesity, family history of PCOS among first-degree relatives, premature adrenarche, fetal androgen exposure, and low birth weight [1]
Risk Factors
Common risk factors in the development of Polycystic ovary syndrome are
- Hyperinsulinemia secondary to insulin resistance; associated with type 2 diabetes mellitus[1]
- Obesity
- Family history of PCOS among first-degree relatives
- Premature adrenarche
- Fetal androgen exposure
- Low birth weight
References
- ↑ 1.0 1.1 Sortino MA, Salomone S, Carruba MO, Drago F (2017). "Polycystic Ovary Syndrome: Insights into the Therapeutic Approach with Inositols". Front Pharmacol. 8: 341. doi:10.3389/fphar.2017.00341. PMC 5463048. PMID 28642705.